Cart
sales@molnova.com
Thioisonicotinamide
CAS No. 2196-13-6
Thioisonicotinamide( NSC 1607 | Thioisonicotinamide )
Catalog No. M13498 CAS No. 2196-13-6
Isonicotinamide (pyridine-4-carboxamide) is a chemical based on the nicotinamide structure, but in which the amide is in the 4-position and not the 3-position.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 28 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | 27 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameThioisonicotinamide
-
NoteResearch use only, not for human use.
-
Brief DescriptionIsonicotinamide (pyridine-4-carboxamide) is a chemical based on the nicotinamide structure, but in which the amide is in the 4-position and not the 3-position.
-
DescriptionIsonicotinamide (pyridine-4-carboxamide) is a chemical based on the nicotinamide structure, but in which the amide is in the 4-position and not the 3-position.
-
In Vitro——
-
In Vivo——
-
SynonymsNSC 1607 | Thioisonicotinamide
-
PathwayMicrobiology/Virology
-
TargetAntibiotic
-
RecptorTubercle bacillus
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2196-13-6
-
Formula Weight138.19
-
Molecular FormulaC6H6N2S
-
Purity>98% (HPLC)
-
SolubilityLimited solubility
-
SMILESNC(=S)C1=CC=NC=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Yamamoto K, et al.Saishin Igaku. 1967 Sep 10;22(9):2087-97.
molnova catalog
related products
-
VP-4604
VP-4604 is a potent anti-methicillin-resistant Staphylococcus aureus (MRSA) compound that exhibited significant microbial growth inhibition against S. aureus with an MIC of 4-8 μg/mL and a growth inhibition rate of over 95%.
-
Phleomycin D1
Phleomycin D1 (PLM D1), a glycopeptide antibiotic in the Bleomycin/Phleomycin family, induces cell death by binding to and cleaving DNA .
-
anti-TB agent 1
Anti-TB agent 1 is a potent and orally active anti-tuberculosis compound (MICs: < 2 nM against the Mtb strains H37Rv, rRMP, and rINH).
